• 제목/요약/키워드: Microencapsulation

검색결과 165건 처리시간 0.04초

미세캡슐화한 녹차 및 자몽종자 추출물이 Murine RAW 264.7 대식세포주의 항염증에 미치는 영향 비교 (A comparison of anti-inflammatory activities of green tea and grapefruit seed extract with those of microencapsulated extracts)

  • 전윤경;김명환;성필남;장문정
    • Journal of Nutrition and Health
    • /
    • 제45권5호
    • /
    • pp.443-451
    • /
    • 2012
  • We compared the effects of grapefruit seed extract (GFSE), green tea extract (GT) and their microencapsulated extract on anti-inflammatory activities in murine RAW 264.7 macrophages cell line. In order to protect the bioactive compounds in the extracts, they were microencapsulated with maltodextrin and $H_2O$. Nitric oxide (NO), prostaglandin E2 (PGE2), tumor necrosis factor-${\alpha}$ (TNF-${\alpha}$), inducible nitric oxide synthase (iNOS) protein expression and thiobarbiturate reactive substances (TBARS) were analyzed in LPS activated RAW 264.7 macrophages. The green tea extract at the range of $100-600{\mu}g/mL$ inhibited NO, PGE2 production and iNOS protein expression without cytotoxicity in a dose-dependent manner. Grapefruit seed extract had strong inhibitory effects on NO and PGE production and iNOS protein expression at the range of $5-20{\mu}g/mL$ without cytotoxicity. Microencapsulation of green tea extract had further inhibitory effects on NO and PGE2 production and on iNOS protein expression, whereas microencapsulated GFSE did not show any further inhibitory effects on these parameters. Taken together, our results suggest that GSFE might be a promising candidate for preventing inflammation related diseases, such as cardiovascular disease, cancer or diabetes, and the microencapsulation of green tea extract could improve its bioactivity.

Microencapsulated basil oil (Ocimum basilicum Linn.) enhances growth performance, intestinal morphology, and antioxidant capacity of broiler chickens in the tropics

  • Thuekeaw, Sureerat;Angkanaporn, Kris;Nuengjamnong, Chackrit
    • Animal Bioscience
    • /
    • 제35권5호
    • /
    • pp.752-762
    • /
    • 2022
  • Objective: Microencapsulation is a technique to improve stability, bioavailability, and controlled release of active ingredients at a target site. This experiment aimed to investigate the effects of microencapsulated basil oil (MBO) on growth performance, apparent ileal digestibility (AID), jejunal histomorphology, bacterial population as well as antioxidant capacity of broiler chickens in a tropical climate. Methods: A total of 288 one-day-old female broilers (Ross 308) were randomly allocated into 4 groups (6 replicates of 12 birds), based on a completely randomized design. Dietary treatments were as follows: i) basal diet (NC), ii) basal diet with avilamycin at 10 ppm (PC), iii) basal diet with free basil oil (FBO) at 500 ppm, and iv) basal diet with MBO at 500 ppm, respectively. Results: Dietary supplementation of MBO improved average daily gain, and feed conversion ratio of broilers throughout the 42-d trial period (p<0.05), whereas MBO did not affect average daily feed intake compared with NC group. The broilers fed MBO diet exhibited a greater AID of crude protein and gross energy compared with those in other groups (p<0.05). Lactobacillus spp. and Escherichia coli populations were not affected by feeding dietary treatments. Both FBO and MBO had positive effects on jejunal villus height (VH), villus height to crypt depth ratio (VH:CD) and villus surface area of broilers compared to NC and PC groups (p<0.05). Superoxide dismutase level in the duodenal mucosa of MBO group was significantly increased (p<0.01), whereas malondialdehyde level was significantly decreased (p<0.01). Conclusion: Microencapsulation could be considered as a promising driver of the basil oil efficiency, consequently MBO at 500 ppm could be potentially used as a feed additive for improvement of intestinal integrity and nutrient utilization, leading to better performance of broiler chickens.

${\omega}-3$계 지방산의 미세캡슬화에 관한 연구 (Studies on the Microencapsulation of ${\omega}-3$ Polyunsaturated Fatty Acid)

  • 김철현;이경욱;백승천;곽해수;강종욱
    • 한국식품과학회지
    • /
    • 제28권4호
    • /
    • pp.743-749
    • /
    • 1996
  • ${\omega}-3$계 지방산을 함유한 어유성분을 미세캡슐화하기위해 최적의 미세캡슐화 조건을 설정하였고 이에따라 분무된 미세캡슐의 열안정성과 보존성 및 효소에 의한 분해율 등을 실험하였다. Agar 1.5%와 gelatin 0.5%(w/w)를 첨가한 처리구의 수율이 97%로 가장 높았으며 유화안정성이 우수한 것으로 나타나 캡슐소재로 선정하였고, HLB값이 4.5인 SFAN 60을 0.5% (w/w) 첨가한 처리구가 가장 수율이 높게 나타나 캡슐소재에 적합한 유화제로 나타났으며, 캡슐소재와 어유의 최적 배합비율은 8 : 2 (w/w)로 나타났다. 정해진 조건에 따라 제조된 미세캡슐의 열안정성은 $40^{\circ}C$처리구에서는 높은 수율을 유지 하였으며, $80^{\circ}C$이상의 처리구에서는 수율이 급격히 감소하여 고온에서의 열안정성이 낮은 것으로 나타났으나, 보존성에 있어 $4^{\circ}C$, $10^{\circ}C$의 냉장온도에서는 7일간 보존시에도 수율의 변화가 거의 없었으며, $20^{\circ}C$, $30^{\circ}C$의 상온에서는 장기간 보존시 수율이 80% 내외로 감소하였다. 또한 미세캡슐용액에 pepsin을 첨가하여 캡슐의 분해정도를 실험한 결과 $80.57{\%}$의 캡슐이 분해되어 섭취시 소화에는 큰 영향이 없을 것으로 생각된다.

  • PDF

Microencapsulation of Lactobacillus plantarum DKL 109 using External Ionic Gelation Method

  • Chun, Honam;Kim, Cheol-Hyun;Cho, Young-Hee
    • 한국축산식품학회지
    • /
    • 제34권5호
    • /
    • pp.692-699
    • /
    • 2014
  • The aim of this study was to apply the external ionic gelation using an atomizing spray device comprised of a spray gun to improve the viability of Lactobacillus plantarum DKL 109 and for its commercial use. Three coating material formulas were used to microencapsulate L. plantarum DKL 109: 2% alginate (Al), 1% alginate/1% gellan gum (Al-GG), and 1.5% alginate/3% gum arabic (Al-GA). Particle size of microcapsules was ranged from 18.2 to $23.01{\mu}m$ depending on the coating materials. Al-GA microcapsules showed the highest microencapsulation yield (98.11%) and resulted in a significant increase in survivability of probiotic in a high acid and bile environment. Encapsulation also improved the storage stability of cells. The viability of encapsulated cells remained constant after 1-mon storage at ambient temperature. The external ionic gelation method using an atomizing spray device and the Al-GA seems to be an efficient encapsulation technology for protecting probiotics in terms of scale-up potential and small microcapsule size.

Development of New Reverse Micellar Microencapsulation Technique to Load Water-Soluble Drug into PLGA Microspheres

  • Kim Hyun Joo;Cho Mi Hyun;Sah Hong Kee
    • Archives of Pharmacal Research
    • /
    • 제28권3호
    • /
    • pp.370-375
    • /
    • 2005
  • The objective of this study was to develop a new reverse micelle-based microencapsulation technique to load tetracycline hydrochloride into PLGA microspheres. To do so, a reverse micellar system was formulated to dissolve tetracycline hydrochloride and water in ethyl formate with the aid of cetyltrimethylammonium bromide. The resultant micellar solution was used to dissolve 0.3 to 0.75 g of PLGA, and microspheres were prepared following a modified solvent quenching technique. As a control experiment, the drug was encapsulated into PLGA microspheres via a conventional methylene chloride-based emulsion procedure. The micro­spheres were then characterized with regard to drug loading efficiency, their size distribution and morphology. The reverse micellar procedure led to the formation of free-flowing, spherical microspheres with the size mode of 88 ~m. When PLGA microspheres were prepared follow­ing the conventional methylene chloride-based procedure, most of tetracycline hydrochloride leached to the aqueous external phase: A maximal loading efficiency observed our experimental conditions was below $5\%$. Their surfaces had numerous pores, while their internal architecture was honey-combed. In sharp contrast, the new reverse micellar encapsulation technique permitted the attainment of a maximal loading efficiency of 63.19 $\pm$$0.64\%$. Also, the microspheres had smooth and pore-free surfaces, and hollow cavities were absent from their internal matrices. The results of this study demonstrated that PLGA microspheres could be successfully prepared following the new reverse micellar encapsulation technique.

PLGA 미립구로부터 PLGylated G-CSF의 서방성 방출 (Sustained Release of PLGylated G-CSF from PLGA Microsphere)

  • 정경환;임형권;이시욱;강관엽;박태관
    • KSBB Journal
    • /
    • 제17권1호
    • /
    • pp.33-37
    • /
    • 2002
  • PLGA 미립구로부터 G-CSF의 방출 거동 양상을 향상 시키기 위하여 G-CSF를 분자량 5000인 methoxy polyethylene glycol-aldehyde로 PEGylation 시켰다. 대부분의 G-CSF는 mono-PEGylation 되었으며, 이를 SDS-PAGE, HPLC, 및 펩타이드 지도 분석을 통해 확인하였다. W/O/W 방법을 사용하여 G-CSF 및 PEGylated G-CSF의 PLGA 미립구를 제조하였으며, 이때 봉입율은 높은 상태였다. 미립구내로 더 많은 G-CSF를 봉입하기 위하여 액상의 G-CSF 및 PEGylated G-CSF을 농축하였고 native gel과 gel filtration 크로마토 그래피를 통하여 단백질이 안정함을 확인하였다. 이렇게 제조한 PLGA 봉입체의 in vitro 방출 거동을 조사한 결과 PEGylated G-CSF는 native G-CSF에 비하여 더 오랜 시간 동안 방출이 지속되었고 최대 방출량도 증가하였다.

Microencapsulation of Isoprinosine with Ethylcellulose

  • Kim, Chong-Kook;Hwang, Sung-Joo
    • Archives of Pharmacal Research
    • /
    • 제14권4호
    • /
    • pp.298-304
    • /
    • 1991
  • Isoprinosine, an antiviral agent with a bitter taste, has been clinically used up to a maximum of 4 g daily in 4-8 doses. In this investigation, isoprinosine was microencapsulated with ethylcellulose 22 cps, 50 cps and 100 cps by means of polymer deposition from cyclohexane through temperature change. Complete removal of cyclohexane from the microcapsules was necessary, since ethylcellulose-coated microcapsules obtained from cyclohexane medium were heavily solvated with cyclohexane and formed lumps even after drying. The displacement of cyclohexane by n-hexane during isolation of microcapsules (Method III) or the freezing of the anal-washed microcapsules before drying (Mothod II) provided the dried products which were more discrete microcapsules than those which were simply dried in the air overnight (Method I). Method III was especially the most effective procedure in preparing finer and more discrete microcapsules. The drug-release from microcapsules was influenced by the ratio of core to wall, the viscosity grade of ethylcellulose and the overall microcapsule size. The release rate was adequately fitted to both the first-order and the diffusion-controlled processes. It is therefore possible to design the release-controlled microcapsules with ethylcellulose of different viscosity along with various core to wall ratio.

  • PDF

Microencapsulated ${\beta}-Galactosidase$에 의한 우유 유당의 가수 분해 (Hydrolysis of Lactose in Milk by Microencapsulated ${\beta}-Galactosidase$)

  • 백옥련;로사위;변시명
    • 한국식품과학회지
    • /
    • 제12권1호
    • /
    • pp.45-52
    • /
    • 1980
  • E. coli로부터 분리 정제한 ${\beta}-galactosidase$를 1,6-diaminohexane과 sebacoyl chloride를 사용하여 계면증합 반응에 의하여 나일론 막에 microencapsulation 시켜 고정화 시켰다. 얻어진 microcapsule은 구형이었고 평균 직경이 $80{\mu}$이었으며 이 방법에 의하여 microencapsulation 시킨 ${\beta}-galactosidase$의 효소 역가 효율은 45%이었다. 유당의 막 투과는 거의 완전하게 이루어졌다. Microencapsulation 시킨 ${\beta}-galactosidase$의 성질은 가용성 효소와 거의 비슷하였고 최적 pH는 $7.0{\sim}7.2$에서 $7.3{\sim}7.5$로 약간 이동하였으며, 최적 온도는 $50^{\circ}C,\;K_m$값은 o-nitrophenyl-${\beta}$-D-galactopyranoside(ONPG)와 유당에 대하여 가용성 효소는 각각 $3.33{\times}10^{-4},$$2.86{\times}10^{-3}M$ 이었고 고정화 효소는 $5.28{\times}10^{-4}$$4.25{\times}10^{-3}M$이었다. 활성화 에너지는 가용성 효소는 8.94와 고정화 효소는 9.78 Kcal/mole이었다. 이 고정화 효소를 사용하여 5% 표준 유당 용액과 탈지 우유에 존재하는 유당을 가수 분해한 결과 40시간안에 각각 80 및 70%씩 가수 분해 하였다. 또한 공정중의 고정화 효소의 안정성을 살펴 본 결과 $27^{\circ}C$에서 한번에 24시간씩 5번 사용 후 남아 있는 역가는 50%로서 실제 이용상 긍정적인 결과를 나타내었다.

  • PDF

혈액대용물질의 제조 및 특성 평가 (Estimate of Characteristics and Manufacture of Blood Substitutes)

  • 김기범;박재관;김성종;김종수;유일수;김민호;홍철운;김진상;강형섭
    • Korean Chemical Engineering Research
    • /
    • 제46권3호
    • /
    • pp.626-632
    • /
    • 2008
  • 본 연구는 헤모글로빈을 계란의 인지질로 microencapsulation한 hemosome과 PFC 유화액을 제조하여 산소전달 특성을 향상시키고자 하였다. 실험결과 fluosol-DA를 sonication하여 평균입자크기가 437 nm의 안정성 있는 유화액을 제조할 수 있었으며, glycerol의 농도를 증가시킴으로써 유화시간을 줄이고 안정도를 높일 수 있었다. 소 혈액으로부터 추출한 헤모글로빈을 달걀노른자로부터 추출한 인지질로 microencapsulation하여 직경 $0.8{\mu}m$의 hemosome을 얻을 수 있었다. Hemosome의 산소포화도 곡선은 정상혈액의 적혈구와 같이 S자형을 보였으며 $P_{50}$은 24 mmHg이었다. Hemosome과 혈액을 1:4(V/V%)의 혼합한 혼합용액에서의 산소 포화도는 정상혈액과 유사한 결과를 보였으며, PFC 유화액과 혈액을 1:4(V/V%)로 혼합한 혼합용액에도 정상혈액과 유사한 결과를 보였다.